Advertisement

Search Results for "Pharmacovigilance Conference"

08:33 EDT 21st May 2013 | BioPortfolio

Original Source: Conference - 6th Annual Pharmacovigilance

Examining latest developments in pharmacovigilance, drug safety and risk management to ensure safer drugs to market

Matching Channels

BioPortfolio - life science, medical devices and pharmaceutical conference

BioPortfolio is an internet agent for Visiongain's life science, medical devices and pharmaceutical conference.

Management Forum - highest quality conference, seminar and knowledge-based experiences

Since 1983, Management Forum have built a reputation on providing the highest quality conference, seminar and knowledge-based experiences for leading professionals in some of the world's most...

Matching News

Training for New Pharmacovigilance Framework

Published date:  06/06/2012 Summary:  Training for New Pharmacovigilance Framework...

EMA finalises pharmacovigilance guidance

EMA announced on 25 June 2012 the release of the finalised versions of seven new guideline modules outlining good pharmacovigilance practices (GVPs) to assist sponsors with complying with the soon-to-...

EMA consults on risk-based auditing of pharmacovigilance systems, communicating safety info

The European Medicines Agency is seeking feedback on two draft modules to be included in its good pharmacovigilance practice guideline (GVP). The latest modules pertain to pharmacovigilance audits an...

News and press releases: The PROTECT project on pharmacovigilance achieves key objectives

The PROTECT project, a Public-Private Partnership for new methodologies in pharmacovigilance and pharmacoepidemiology coordinated by the European Medicines Agency, has reached a crucial stage with the...

PROTECT project on pharmacovigilance achieves key objectives, says EMA

The PROTECT project, a public-private partnership for innovative methodologies in pharmacovigilance and pharmacoepidemiology coordinated by the European Medicines Agency, has reached a crucial stage w...

Will The New EU Pharmacovigilance Legislation Fulfil Its Purpose? 24-25 January 2013, Madrid

With the aim of improving the protection of public health, the EU has redefined the practice of pharmacovigilance with new legislation that took effect in July 2012. Better protection of patients by s...

Appel Consulting’s 2nd Annual Pharmacovigilance Conference, where our expert panel of speakers, will share insights on ‘exploring innovation’, pivotal to achieve success in the global pharmacovigilance field

October 30th 2012: Join us at Appel Consulting’s 2nd Annual Pharmacovigilance Conference, where our expert panel of speakers, will share insights on ‘exploring innovation’, pivo...

How to Ensure Pharmacovigilance Practices are Compliant with Global Safety Requirements: Challenges in Asia-Pacific

Toronto, Canada (PRWEB) January 21, 2013 National Regulators enact various Pharmacovigilance (PV) regulations in order to ensure that medicines and medical devices are acceptably safe. The regulati...

Matching PubMed Articles

Importance of cytochrome P450 (CYP450) in adverse drug reactions due to drug-drug interactions: a PharmacoVigilance study in France.

OBJECTIVE: Our aim was to characterize Adverse Drug Reactions (ADRs) related to drug-drug interactions (DDIs) related to involvement of cytochrome P450 (CYP450) isoenzymes in a pharmacovigilance datab...

Pharmacovigilance teaching in UK undergraduate pharmacy programmes.

PURPOSE: Pharmacists in the UK are able to report spontaneous adverse drug reactions (ADRs) to the Medicines and Healthcare Products Regulatory Authority. The level of reporting by UK pharmacists rema...

The knowledge, perceptions and practice of pharmacovigilance amongst community pharmacists in Lagos state, south west Nigeria.

PURPOSE: Community Pharmacists both have an important responsibility in monitoring the ongoing safety of medicines and are widely accessible to do it. This study aims to investigate the knowledge, per...

Pharmacovigilance and biosimilars: considerations, needs and challenges.

Introduction: Biosimilars are biologic medicines that are highly similar to approved biologics, notwithstanding minor differences in clinically inactive components. Since 2007, biosimilars have been a...

Sarcoïdosis and Anti-TNF: a Paradoxial Class Effect? Analysis of the French Pharmacovigilance System Database and Literature Review.

Objectives. To identify and characterize the observations of sarcoidosis occurring during anti-TNF blockade collected in the French Pharmacovigilance system database and reported in the literature. Re...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement